Prime Minister Kretschmer spoke out clearly in the state parliament regarding the pharmaceutical company GSK's plans to close ...
GSK plc is returning to China for another oncology asset, agreeing to acquire global rights to a preclinical trispecific T-cell engager from Chimagen Biosciences in a deal worth up to $750 million.
GSK is consolidating its vaccine manufacturing operations to one site—located in Canada—amid what a spokesperson said is ...
GSK said on Tuesday it had agreed a deal worth up to $750 million ​to buy a trispecific T cell-engager (TCE), a drug ‌designed to help T-cells target cancer, from China-based biotechnology firm ...
Read Coronavirus vaccine latest news on The Economic Times. When will coronavirus vaccine be available in India? Coronavirus ...
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
4don MSN
Why is GSK stock gaining Monday?
On Monday, GSK plc GSK stock is trading higher on highly positive clinical data from two separate lung cancer trials, ...
GSK is consolidating two of its influenza vaccine manufacturing sites into one, leaving hundreds of jobs at risk. | GSK is ...
GSK is advancing its inaugural lung cancer asset, Jideytro, toward a landmark first-line FDA approval, aided by an ...
GSK is paying $110 million upfront to Hutchmed in a deal worth up to $1.295 billion. Now in its fifth year, the MM+M Media Summit 2026 brings together trailblazers from across health media and pharma ...
DeepIntent launched Cora, an AI platform with multiple agents designed to let healthcare marketers execute tasks with ...
One-Year Analytical Tool Delivers Near-Real-Time Pipeline Alerts on 319 Targets/Antigens/Armor and 1,200+ Funding Rounds as GlaxoSmithKline, BioNTech, and Inovio Lead a Field That Saw 76 New Vaccines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results